If you work with biomarker discovery, don’t miss out on this free eBook exploring how scientists can utilize multiplexing immunoassay technology in their research to generate more answers in less time with better reproducibility. See some of the eBook highlights and download it for yourself today!
If you work with biomarker discovery, don’t miss out on this free eBook exploring how scientists can utilize multiplexing immunoassay technology in their research to generate more answers in less time with better reproducibility. See some of the eBook highlights and download it for yourself today!
If you work with biomarker discovery, don’t miss out on this free eBook exploring how scientists can utilize multiplexing immunoassay technology in their research to generate more answers in less time with better reproducibility. See some of the eBook highlights and download it for yourself today!
At Immunology2022™, this year’s meeting of the American Association of Immunologists, Eric Rogier, a microbiologist from the CDC, offered an exciting presentation about utilizing bead-based multiplex assays for generating epidemiological and immunological data about malaria. In his presentation, he reported how antigen and antibody tests generate important data for characterizing population-level trends, individual immune responses, and more. See the full findings from his presentation at AAI here.
VRL specializes in monitoring the health of animals used in research studies, though it also performs services for veterinarians in other areas of animal health. In its laboratory facilities, VRL scientists aim to detect viruses, bacteria, parasites, and other pathogens that could make animals sick. They have implemented xMAP® Technology to deliver better, more accurate results within a shorter time frame and became a Luminex Licensed Technologies Partner, receiving early access to new kits and products as well as enhanced support.
To better understand a candidate therapy for neurodegenerative disorders, researchers needed an easy-to-use technology. At the Labroots-hosted Neuroscience 2022 meeting, Diana Price from Neuropore Therapies offered a fascinating presentation about how her team is using xMAP® multiplexing technology to characterize candidate therapies in order to treat Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and other neurodegenerative disorders.
To celebrate the great diversity of xMAP-enabled applications in the research community, we’ve pulled together a sampling of recent publications showing how this technology is being used beyond human health needs. From animals to viruses and more, here’s a look at the utility of bead-based multiplexing in a variety of applications.
Oncimmune scientists are using autoantibodies as biomarkers for a broad range of immuno-oncology studies. This work is made possible with bead-based multiplexing xMAP® Technology, which allows the team to cost-effectively and rapidly query for hundreds or thousands of biomarkers in large numbers of samples.
There is growing recognition that autoantibodies—antibodies directed against someone’s own proteins—represent an exciting class of biomarkers important for revealing interactions between the immune system and cancer. For high-throughput autoantibody studies, scientists at Oncimmune, our latest Luminex Licensed Technology Partner, rely on xMAP® Technology
Confused by the wide selection of multiplexing options? This eBook can illuminate the differences between them to help you make an informed decision.